1,25(OH)2D3
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 12 |
Source: | FDA Structured Product Label |
---|
Side effects: | 14 |
Source: | FDA Structured Product Label |
---|
Side effects: | 38 |
Source: | FDA |
---|
Side effects: | 33 |
Source: | FDA Structured Product Label |
---|
Side effects: | 35 |
Source: | FDA Structured Product Label |
---|
Side effects: | 35 |
Source: | FDA Structured Product Label |
---|
Side effects: | 41 |
Source: | FDA Structured Product Label |
---|
Side effects: | 47 |
Source: | medicines.org.au |
---|
Side effects: | 46 |
Source: | medicines.org.au |
---|
Side effects: | 49 |
Source: | FDA Structured Product Label |
---|
Side effects: | 49 |
Source: | Health Canada |
---|
Side effects: | 50 |
Source: | Health Canada |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|